title: Neoadjuvant Tyrosine Kinase Downstaging of T2 Renal Cell Carcinoma in Solitary Kidney Before Robotic Partial Nephrectomy.
abstract: We highlight the use of a tyrosine kinase inhibitor, pazopanib, for neoadjuvant downstaging a 7.4 cm right biopsy-proven clear cell renal-cell carcinoma in a solitary kidney before surgical intervention of robotic partial nephrectomy with retrograde cooling to induce cold ischemia in a 79-year-old male.
authors: Department of Urology, Tulane University School of Medicine , New Orleans, Louisiana.
authors: Mary K
authors: MK
authors: Powers
authors: Department of Urology, Tulane University School of Medicine , New Orleans, Louisiana.
authors: Oliver
authors: O
authors: Sartor
authors: Department of Urology, Tulane University School of Medicine , New Orleans, Louisiana.
authors: Benjamin R
authors: BR
authors: Lee